Roberto Vargas, MD
机构: Staff, Gynecologic Oncology, Cleveland Clinic
每年引用次数
引用次数
引用: 1,760
H-指数: 18
I10-指数 : 23
出版物: 98
Appendiceal adhesion to synthetic mesh after laparoscopic sacrocolpopexy: a case report.
Roberto Vargas , Anna Keryan , Vatche A. Minassian
International Urogynecology Journal 26 ( 1) 155 -157
2015
Racial disparity in survival of patients with uterine serous carcinoma: Changes in clinical characteristics, patterns of care and outcomes over time from 1988 to 2011.
Haider Mahdi , Xiaozhen Han , Fadi Abdul-Karim , Roberto Vargas
Gynecologic Oncology 143 ( 2) 334 -345
7
2016
Disruption of the gut microbiota attenuates epithelial ovarian cancer sensitivity to cisplatin therapy
Laura M Chambers , Emily L Esakov , Chad Braley , Lexie Trestan
bioRxiv
1
2020
Use of prophylactic closed incision negative pressure therapy is associated with reduced surgical site infections in gynecologic oncology patients undergoing laparotomy
Laura Moulton Chambers , Molly Morton , Erika Lampert , Meng Yao
American Journal of Obstetrics and Gynecology 223 ( 5) 731.e1 -731.e9
2
2020
Elevated plasma tissue inhibitor of metalloproteinase-1 levels predict decreased survival in castration-resistant prostate cancer patients
William K. Oh , Roberto Vargas , Susanna Jacobus , Kim Leitzel
Cancer 117 ( 3) 517 -525
26
2011
Effects of electrosurgery and vaginal closure technique on postoperative vaginal cuff dehiscence.
James Fanning , Joshua Kesterson , Matthew Davies , Janis Green
Jsls-journal of The Society of Laparoendoscopic Surgeons 17 ( 3) 414 -417
18
2013
The microbiome and gynecologic cancer: current evidence and future opportunities
Laura M Chambers , Parker Bussies , Roberto Vargas , Emily Esakov
Current Oncology Reports 23 ( 8) 92
15
2021
Disruption of the gut microbiota confers cisplatin resistance in epithelial ovarian cancer
Laura M Chambers , Emily L Esakov Rhoades , Rashmi Bharti , Chad Braley
Cancer research 82 ( 24) 4654 -4669
4
2022
The gut microbiome attenuates epithelial ovarian cancer growth and platinum sensitivity: Novel opportunities for ovarian cancer treatment
L Moulton Chambers , Emily L Esakov , Chad Braley , Naseer Sangwan
Gynecologic Oncology 159 108 -109
1
2020
Abstract B090: Gut microbial suppression of epithelial ovarian cancer and attenuation of chemoresistance: opportunity for probiotics in patient care to improve survival
Ofer Reizes , Laura Chambers , Chad M Michener , Mark Brown
Cancer Research 84 ( 5_Supplement_2) B090 -B090
2024
Elevated plasma TIMP-1 levels predict reduced survival in metastatic castration-resistant prostate cancer patients.
Roberto Vargas , Susanna Jacobus , Kim Leitzel , Meredith Regan
Cancer Research 68 ( 9_Supplement) 996 -996
2
2008
Alcohol accelerates loss of muscle and impairs recovery of muscle mass resulting from disuse atrophy
Roberto Vargas , Charles H Lang
Alcoholism: Clinical and Experimental Research 32 ( 1) 128 -137
61
2008
Cell surface CD55 traffics to the nucleus leading to cisplatin resistance and stemness by inducing PRC2 and H3K27 trimethylation on chromatin in ovarian cancer
Rashmi Bharti , Goutam Dey , Debjit Khan , Alex Myers
Molecular Cancer 23 ( 1) 121 -121
2024
NCCN guidelines® insights: Ovarian cancer, version 3.2022: Featured updates to the NCCN guidelines
Deborah K Armstrong , Ronald D Alvarez , Floor J Backes , Jamie N Bakkum-Gamez
Journal of the National Comprehensive Cancer Network 20 ( 9) 972 -980
155
2022
Evolutionary experimentation highlights collateral sensitivity and associated gene-expression changes in endometrial cancer cell lines (2262)
Sabrina Bedell , Aaron Petty , Arda Durmaz , Jacob Scott
Gynecologic Oncology 176 S292 -S293
2023
MDM2 inhibition as a novel radio-sensitizing strategy for endometrial cancer
Aaron Petty , Brian Yard , Arda Durmaz , Jacob Scott
Cancer Research 83 ( 7_Supplement) 1091 -1091
2023
Dominant-negative TP53 variants confer radiation resistance in endometrial cancer
Aaron Petty , Arda Durmaz , Brian Yard , Jacob Scott
Cancer Research 83 ( 7_Supplement) 1090 -1090
2023
Divergent evolutionary response to multiple fractions of radiation (MF2) therapy in cervical cancer cell lines (CCCL)
Johanna Kelley , Arda Durmaz , Michelle Kuznicki , Aaron Petty
Cancer Research 83 ( 7_Supplement) 2403 -2403
2023
Leveraging the p53 signaling pathway as a radio-sensitization strategy in endometrial cancer
Roberto Vargas , Aaron Petty , Brian Yard , Arda Durmaz
bioRxiv 2022.09. 06.505009 -2022.09. 06.505009
2022
Bridging the Gap from Bench to Bedside: A Call for In Vivo Preclinical Models to Advance Endometrial Cancer and Cervical Cancer Immuno-oncology Research
Laura Chambers , Paulina Haight , Julia Chalif , Yogita Mehra
Clinical Cancer Research OF1 -OF5
2024